Application Nr Approved Date Route Status External Links
NDA022308 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Besivance ® (besifloxacin Ophthalmic Suspension) 0.6%, Is Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Isolates Of The Following Bacteria: Aerococcus Viridans* Cdc Coryneform Group G Corynebacterium Pseudodiphtheriticum* Corynebacterium Striatum* Haemophilus Influenzae Moraxella Catarrhalis* Moraxella Lacunata* Pseudomonas Aeruginosa* Staphylococcus Aureus Staphylococcus Epidermidis Staphylococcus Hominis* Staphylococcus Lugdunensis* Staphylococcus Warneri* Streptococcus Mitis Group Streptococcus Oralis Streptococcus Pneumoniae Streptococcus Salivarius* *efficacy For This Organism Was Studied In Fewer Than 10 Infections. Besivance ® (besifloxacin Ophthalmic Suspension) 0.6% Is A Quinolone Antimicrobial Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Isolates Of The Following Bacteria: Aerococcus Viridans *, Cdc Coryneform Group G, Corynebacterium Pseudodiphtheriticum*, Corynebacterium Striatum*, Haemophilus Influenzae, Moraxella Catarrhalis*, Moraxella Lacunata*, Pseudomonas Aeruginosa*, Staphylococcus Aureus, Staphylococcus Epidermidis, Staphylococcus Hominis*, Staphylococcus Lugdunensis*, Staphylococcus Warneri*, Streptococcus Mitis Group , Streptococcus Oralis, Streptococcus Pneumoniae, Streptococcus Salivarius* *efficacy For This Organism Was Studied In Fewer Than 10 Infections. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Besifloxacin BESIFLOXACIN ZINC3787097

Comments